{
  "@type": "NewsArticle",
  "identifier": "2022--08--25--en--myfeed--katherine-j-wu--NewsArticle--9e57c79465d0b17f8f7f021aea6d506a",
  "url": "https://www.theatlantic.com/health/archive/2022/08/omicron-booster-vaccine-only-plan/671233/?utm_source=feed",
  "headline": "America’s Fall Booster Plan Has a Fatal Paradox",
  "publisher": {
    "@type": "Organization",
    "name": "www.theatlantic.com",
    "url": "https://www.theatlantic.com/feed/all/"
  },
  "description": "New boosters that target Omicron may be our most important COVID vaccines since 2020—but the U.S. may be setting up the new shots to fail.",
  "keywords": [],
  "author": {
    "@type": "Person",
    "name": "Katherine J. Wu",
    "url": "https://www.theatlantic.com/feed/all/"
  },
  "discussionUrl": "https://www.theatlantic.com/health/archive/2022/08/omicron-booster-vaccine-only-plan/671233/?utm_source=feed",
  "sameAs": "https://www.theatlantic.com/health/archive/2022/08/omicron-booster-vaccine-only-plan/671233/?utm_source=feed",
  "dateCreated": "2022-08-25T18:54:01.501Z",
  "datePublished": "2022-08-25T18:35:47.000Z",
  "dateModified": "2022-08-25T18:54:01.501Z",
  "interactionStatistic": []
}